Your browser doesn't support javascript.
loading
Validation of China Health-Related Outcomes Measures-Cardiovascular Disease.
Li, Xue; Li, Rui; Xiao, Feiyi; Zhao, Kun; Zhang, Xiaolu; Wang, Xinyi; Li, Meichen; Guo, Ke; Wang, Li; Wu, Yanan; Van Spall, Harriette; Gao, Tiantian; Fu, Qiang; Xie, Feng.
Afiliación
  • Li X; Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada; Department of Health Technology Assessment, China National Health Development Research Center, Beijing, Beijing, China.
  • Li R; Department of Health Technology Assessment, China National Health Development Research Center, Beijing, Beijing, China; Evidence Based Social Science Research Center/Health Technology Assessment Center, Lanzhou University, Lanzhou, Gansu, China; Evidence-Based Medicine Center, Lanzhou University, La
  • Xiao F; Department of Health Technology Assessment, China National Health Development Research Center, Beijing, Beijing, China.
  • Zhao K; Department of Health Technology Assessment, China National Health Development Research Center, Beijing, Beijing, China; Vanke School of Public Health, Tsinghua University, Beijing, Beijing, China.
  • Zhang X; School of Business Administration, Shenyang Pharmaceutical University, Shenyang, Liaoning, China.
  • Wang X; School of Business Administration, Shenyang Pharmaceutical University, Shenyang, Liaoning, China.
  • Li M; School of Business Administration, Shenyang Pharmaceutical University, Shenyang, Liaoning, China.
  • Guo K; Evidence Based Social Science Research Center/Health Technology Assessment Center, Lanzhou University, Lanzhou, Gansu, China; Evidence-Based Medicine Center, Lanzhou University, Lanzhou, Gansu, China.
  • Wang L; School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing, Jiangsu, China.
  • Wu Y; Evidence Based Social Science Research Center/Health Technology Assessment Center, Lanzhou University, Lanzhou, Gansu, China; Evidence-Based Medicine Center, Lanzhou University, Lanzhou, Gansu, China.
  • Van Spall H; Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada; Department of Medicine, McMaster University, Hamilton, Ontario, Canada; Research Institute of St Joseph's and Population Health Research Institute, Hamilton, Ontario, Canada.
  • Gao T; Shandong Provincial Hospital affiliated to Shandong First Medical University, Jinan, Shandong, China.
  • Fu Q; Department of Health Technology Assessment, China National Health Development Research Center, Beijing, Beijing, China; China National Health Development Research Center, Beijing, Beijing, China.
  • Xie F; Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada; Centre for Health Economics and Policy Analysis, McMaster University, Hamilton, Ontario, Canada. Electronic address: fengxie@mcmaster.ca.
Value Health ; 27(4): 490-499, 2024 04.
Article en En | MEDLINE | ID: mdl-38244982
ABSTRACT

OBJECTIVES:

China Health-Related Outcomes Measures (CHROME) was an initiative aimed at developing a system of preference-based health-related quality of life instruments for China. CHROME-cardiovascular disease (CVD) is a CVD-specific instrument with 14 items developed under this initiative. This study aimed to test the psychometric properties of CHROME-CVD.

METHODS:

This validation study was conducted using cross-sectional questionnaire survey in China. Eligible patients with CVD were recruited and asked to complete the CHROME-CVD, the EQ-5D-5L, and a CVD-specific nonpreference-based health-related quality of life instrument selected according to the confirmed diagnosis of the patients. Item evaluation, internal consistency, measurement invariance, test-retest reliability, structural validity, and construct validity were tested using classic test theory. Item response theory was used to evaluate item-level performance.

RESULTS:

A total of 444 patients with CVD (coronary artery disease, n = 276, heart failure, n = 104, angina, n = 33, and atrial fibrillation, n = 16) from 6 provinces in China were enrolled for the validation. Exploratory factor analysis identified 4 factors chest pain, other symptoms, physical health, and mental and social health. Cronbach's alpha and intraclass correlation coefficient were >0.8. A total of 20 of 26 (76.9%), and 90 of 95 (94.7%) predefined hypotheses were met for convergent and discriminant validities, respectively. No important difference was identified between subgroups of gender and residency. Response options of 10 items were found overlapped based on categorical response curves, which led to modification to 4-level response options. Wording of 3 items were modified by referring wordings of reference instruments.

CONCLUSION:

The validation of the CHROME-CVD demonstrated generally good psychometric properties. Further validation on the modified CHROME-CVD is needed.
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Calidad de Vida / Enfermedades Cardiovasculares Tipo de estudio: Prognostic_studies Límite: Humans País/Región como asunto: Asia Idioma: En Revista: Value Health Asunto de la revista: FARMACOLOGIA Año: 2024 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Calidad de Vida / Enfermedades Cardiovasculares Tipo de estudio: Prognostic_studies Límite: Humans País/Región como asunto: Asia Idioma: En Revista: Value Health Asunto de la revista: FARMACOLOGIA Año: 2024 Tipo del documento: Article País de afiliación: China